These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Antibody-dependent, cell-mediated cytotoxicity by an anti-class II murine monoclonal antibody: effects of recombinant interleukin 2 on human effector cell lysis of human B-cell tumors. Biddle WC; Pancook J; Goldrosen M; Han T; Foon KA; Vaickus L Cancer Res; 1990 May; 50(10):2991-6. PubMed ID: 2334902 [TBL] [Abstract][Full Text] [Related]
3. Cytokine influence on killing of fresh chronic lymphocytic leukemia cells by human leukocytes. Cemerlíc D; Dadey B; Han T; Vaickus L Blood; 1991 Jun; 77(12):2707-15. PubMed ID: 1904285 [TBL] [Abstract][Full Text] [Related]
4. Monoclonal Lym-1 antibody-dependent lysis of B-lymphoblastoid tumor targets by human complement and cytokinine-exposed mononuclear and neutrophilic polymorphonuclear leukocytes. Ottonello L; Morone P; Dapino P; Dallegri F Blood; 1996 Jun; 87(12):5171-8. PubMed ID: 8652830 [TBL] [Abstract][Full Text] [Related]
5. Evaluating antibodies for their capacity to induce cell-mediated lysis of malignant B cells. Würflein D; Dechant M; Stockmeyer B; Tutt AL; Hu P; Repp R; Kalden JR; van de Winkel JG; Epstein AL; Valerius T; Glennie M; Gramatzki M Cancer Res; 1998 Jul; 58(14):3051-8. PubMed ID: 9679970 [TBL] [Abstract][Full Text] [Related]
6. Fc gamma RI and Fc gamma RII on monocytes and granulocytes are cytotoxic trigger molecules for tumor cells. Graziano RF; Fanger MW J Immunol; 1987 Nov; 139(10):3536-41. PubMed ID: 2960735 [TBL] [Abstract][Full Text] [Related]
7. HLA class II as potential target antigen on malignant B cells for therapy with bispecific antibodies in combination with granulocyte colony-stimulating factor. Elsässer D; Valerius T; Repp R; Weiner GJ; Deo Y; Kalden JR; van de Winkel JG; Stevenson GT; Glennie MJ; Gramatzki M Blood; 1996 May; 87(9):3803-12. PubMed ID: 8611706 [TBL] [Abstract][Full Text] [Related]
8. Granulocyte Fc gamma receptor recognition of cell bound and aggregated IgG: effect of gamma-interferon. Ruiz P; Gomez F; Lopez R; Chien P; Rossman MD; Schreiber AD Am J Hematol; 1992 Apr; 39(4):257-63. PubMed ID: 1532472 [TBL] [Abstract][Full Text] [Related]
9. Induction of mouse IgG2a- and IgG3-dependent cellular cytotoxicity in human monocytic cells (U937) by immune interferon. Akiyama Y; Lubeck MD; Steplewski Z; Koprowski H Cancer Res; 1984 Nov; 44(11):5127-31. PubMed ID: 6435864 [TBL] [Abstract][Full Text] [Related]
10. Monoclonal Lym-1 antibody-dependent cytolysis by neutrophils exposed to granulocyte-macrophage colony-stimulating factor: intervention of FcgammaRII (CD32), CD11b-CD18 integrins, and CD66b glycoproteins. Ottonello L; Epstein AL; Dapino P; Barbera P; Morone P; Dallegri F Blood; 1999 May; 93(10):3505-11. PubMed ID: 10233903 [TBL] [Abstract][Full Text] [Related]
11. Polymorphonuclear leukocyte function triggered through the high affinity Fc receptor for monomeric IgG. Shen L; Guyre PM; Fanger MW J Immunol; 1987 Jul; 139(2):534-8. PubMed ID: 2955043 [TBL] [Abstract][Full Text] [Related]
12. Cells of the J774 macrophage cell line are primed for antibody-dependent cell-mediated cytotoxicity following exposure to gamma-irradiation. Duerst R; Werberig K Cell Immunol; 1991 Sep; 136(2):361-72. PubMed ID: 1831405 [TBL] [Abstract][Full Text] [Related]
14. IFN-α augments natural killer-mediated antibody-dependent cellular cytotoxicity of HIV-1-infected autologous CD4+ T cells regardless of major histocompatibility complex class 1 downregulation. Tomescu C; Tebas P; Montaner LJ AIDS; 2017 Mar; 31(5):613-622. PubMed ID: 28225449 [TBL] [Abstract][Full Text] [Related]
15. Induction of porcine granulocyte-mediated tumor cytotoxicity by two distinct monoclonal antibodies against lytic trigger molecules (PNK-E/G7). Wierda WG; Johnson BD; Dato ME; Kim YB J Immunol; 1993 Dec; 151(12):7117-27. PubMed ID: 8258715 [TBL] [Abstract][Full Text] [Related]
16. Protective effects of interferon-gamma on squamous-cell carcinoma of head and neck targets in antibody-dependent cellular cytotoxicity mediated by human natural killer cells. Sung MW; Johnson JT; Van Dongen G; Whiteside TL Int J Cancer; 1996 May; 66(3):393-9. PubMed ID: 8621263 [TBL] [Abstract][Full Text] [Related]
17. Initial trial of bispecific antibody-mediated immunotherapy of CD15-bearing tumors: cytotoxicity of human tumor cells using a bispecific antibody comprised of anti-CD15 (MoAb PM81) and anti-CD64/Fc gamma RI (MoAb 32). Ball ED; Guyre PM; Mills L; Fisher J; Dinces NB; Fanger MW J Hematother; 1992; 1(1):85-94. PubMed ID: 1365020 [TBL] [Abstract][Full Text] [Related]
18. Anti-renal cell carcinoma chimeric antibody G250: cytokine enhancement of in vitro antibody-dependent cellular cytotoxicity. Liu Z; Smyth FE; Renner C; Lee FT; Oosterwijk E; Scott AM Cancer Immunol Immunother; 2002 May; 51(3):171-7. PubMed ID: 11941456 [TBL] [Abstract][Full Text] [Related]
19. Potentiation of tumor lysis by a bispecific antibody that binds to CA19-9 antigen and the Fc gamma receptor expressed by human large granular lymphocytes. de Palazzo IG; Gercel-Taylor C; Kitson J; Weiner LM Cancer Res; 1990 Nov; 50(22):7123-8. PubMed ID: 2146012 [TBL] [Abstract][Full Text] [Related]
20. Neutrophils express the high affinity receptor for IgG (Fc gamma RI, CD64) after in vivo application of recombinant human granulocyte colony-stimulating factor. Repp R; Valerius T; Sendler A; Gramatzki M; Iro H; Kalden JR; Platzer E Blood; 1991 Aug; 78(4):885-9. PubMed ID: 1714327 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]